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multicistronic transgenes, and should be considered alongside other 
factors to guide the assembly of an optimal vectorized monoclonal 
antibody expression cassette.
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rAAVs have emerged as an efficient gene delivery tool. Discovery of 
various natural serotypes and recent development of recombinant 
capsids significantly advanced the transduction efficiency of rAAVs in 
a variety of cells and tissues. On the other hand, much less effort has 
been made for maximizing expression of the rAAV cargo DNA, since 
current AAV vectors mainly rely on well-established promoters for 
gene expression. Among those, CMV and CAG promoters belong to 
the most frequently used strong promoters providing universal activity. 
The capacity of DNA packaging in rAAV capsids is limited (4.7 kb). 
Hence, the large size of the existing strong promoters is a drawback 
in delivering genes and gene editing tools of large sizes, reaching the 
limits of the viral packaging capacity. To improve AAV as a gene therapy 
tool, discovery of small but strong promoters is a crucial step. Here 
we report two new strong mini promoters, called INS84 and GCG110, 
with universal activity in rAAV expression vectors. These promoters 
are only 84 and 135 base pairs in size, respectively. They showed strong 
expression of a reporter transgene from rAAV in human and mouse 
cells and tissues, including human hepatocytes in primary cultures, 
humanized mice in vivo and human pancreatic islet cells. Expression 
levels in these tissues were comparable to those obtained with the much 
larger CAG promoter. Until now, viral vectors utilized (or ‘borrowed’) 
promoters that are characterized in the context of plasmid expression 
vectors or germ-line transgenes. Our strong mini-promoters for 
rAAV expression suggest a new direction for developing promoters 
for viral vectors, specifically that the large size of promoters required 
for expression in the context of plasmid vectors is often not necessary 
for strong expression in an rAAV vector.
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Genetic access to specific cell types through minimally invasive routes 
is of particular interest in basic research and clinical applications. 
Extensive efforts have been made in engineering gene delivery 
vectors, such as recombinant adeno-associated viruses (rAAVs), 
and gene regulatory elements to achieve this goal. Despite many 
interesting candidates, revealed for example from directed evolution 
via M-CREATE (Sripriya Ravindra Kumar et al., Nature Methods, 
2020), histology-based characterization presents a bottleneck due to 
the limited number of variants and/or cell types that can be investigated 
at once. To address this, we have developed ultrasensitive sequential 
FISH (useqFISH) for multiplexed detection of both endogenous and 
barcoded transgene transcripts in intact tissue with single-molecule 
resolution. By combining two amplification strategies (rolling circle 
amplification, RCA, and hybridization chain reaction, HCR), we 
achieved a 2.7- or 6.7-fold increased signal-to-background ratio of 
useqFISH in comparison to one with RCA or HCR only amplification, 
respectively. UseqFISH allowed us to detect endogenous genes with 
a single probe pair (20-nucleotide (nt) for each) and, in transfected 
cell cultures, to distinguish capsid variants with genomes differing by 
only 7-mer peptide modification. We further improved useqFISH by 
establishing an automated single-molecule imaging and microfluidic 
solution exchange system and an analytical pipeline for 3D imaging 
data. To demonstrate the applicability of useqFISH for in vivo AAV 
profiling, we employed this method to further characterize a pool of 
6 AAV capsid variants that we found to be highly efficient for brain-
wide and/or cell-type biased transduction in the mouse brain following 
systemic delivery. We designed unique nucleic acid barcodes (160-nt) 
in the 3’UTR of each viral genome and retro-orbitally injected the 
pooled AAVs into 2 C57BL6/J mice at a dose of 5e10 viral genomes 
(vg) per variant (total 3e11 vg/mouse). For transcript detection, 11 
canonical cell-type markers (e.g., Slc17a7, Gad1, Pvalb, SST, VIP, etc) 
were used together with probes against the viral genome barcodes, to 
characterize the cell-type tropisms of each variant. Next, we designed 
a pool of 103 barcoded AAV genomes carrying 4 tandem repeats of a 
unique miRNA target site. We packaged these genomes into AAV-PHP.
eB and delivered to 3 C57BL6/J mice at a dose of 1e10 vg/variant (total 
~1e12 vg/mouse). Using useqFISH, we were able to assess the ability of 
each miRNA target site to dampen transgene expression in different cell 
types, thereby revealing useful intersectional strategies to refine cell-
type-specific transgene expression with capsid/cargo combinations. 
These results demonstrate that useqFISH allows for high-throughput 
characterization of pooled genetic variants of viral capsids and gene 
regulatory elements in intact tissue and thus enables comprehensive 
profiling of genetic toolkits for precise access to targets of interest.
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Recent years have seen significant progress in AAV capsid engineering 
for gene delivery with increased efficiency and desired cell-type 
specificity to match the needs of pre-clinical research and gene therapy. 
The cellular uptake of AAVs, however, can stop short of the ultimate 
goal of cargo protein production - due to AAV silencing, insufficient 
nuclear transport, inefficient uncoating, failed second-strand synthesis, 
or other still to be discovered mechanisms. Defining the relationship 
between AAV genome uptake, transcription and cargo protein synthesis 
efficiencies in different cell types and tissues can help bypass key 
bottlenecks in gene delivery and guide effective AAV engineering. 
We adapted a recently published in-situ-transcription-based signal 
amplification method, the “Zombie technique” (1), to detect AAV 
genomes in a variety of fixed cells and tissues. Zombie involves 
producing 20 to 380 base-pair long barcode transcripts by exogenously-
supplied T7 phage polymerase, which are then visualized at high 
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